Paper Details

  1. Home
  2. Paper Details

Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.

Author: AlvesCarlos, Batel-MarquesFrancisco, MacedoAna Filipa

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A meta-analysis compared the safety of apixaban and rivaroxaban, two direct Xa coagulation factor inhibitors, in patients undergoing knee and hip arthroplasty. Apixaban was associated with fewer major and total bleeding events after knee arthroplasty compared to rivaroxaban, with no significant differences observed after hip arthroplasty.
Paper Details　
Original Abstract of the Article :
Direct experimental safety comparisons of Xa coagulation factor direct inhibitors, apixaban and rivaroxaban, on their approved therapeutic indications have not been identified. Due to recently raised safety concerns, a meta-analysis was carried out pooling data from studies identified on a Medline a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1074248411427402

データ提供：米国国立医学図書館（NLM）

Comparing Apixaban and Rivaroxaban: A Meta-Analysis of Safety

This meta-analysis delves into the safety profiles of apixaban and rivaroxaban, two anticoagulants often used to prevent blood clots, like two desert explorers comparing the safety of different paths through a treacherous landscape. The researchers pooled data from multiple studies, seeking to identify potential differences in the risk of bleeding associated with these drugs. Their findings suggest that apixaban may be associated with a lower risk of bleeding after knee arthroplasty, offering a safer option for some patients.

A Comparative Journey Through the Desert of Anticoagulation

This meta-analysis, like a careful comparison of different desert routes, reveals potential differences in the safety profiles of apixaban and rivaroxaban. The researchers found that apixaban may be associated with a lower risk of bleeding after knee arthroplasty, suggesting that it could be a safer choice for certain patients. This discovery could have significant implications for patient care, ensuring that individuals receive the most appropriate and safest treatment.

Choosing the Right Path in the Desert of Anticoagulation: A Patient-Centric Approach

The desert of anticoagulation can be a tricky landscape to navigate, requiring careful consideration of potential risks and benefits. This meta-analysis provides valuable information to guide physicians in selecting the most appropriate anticoagulant for their patients. By understanding the unique characteristics of each medication, healthcare professionals can choose the path that offers the best balance of effectiveness and safety for their patients, ensuring a smoother and safer journey through anticoagulation therapy.

Dr. Camel's Conclusion

This meta-analysis, like a desert explorer's map, provides valuable insights into the safety profiles of apixaban and rivaroxaban. The researchers' findings highlight the potential advantages of apixaban in certain clinical settings, suggesting that it could offer a safer option for some patients. By carefully considering the individual needs of each patient, healthcare professionals can navigate the desert of anticoagulation and choose the path that best suits their unique circumstances.

Date :
  1. Date Completed 2013-01-02
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

22134134

DOI: Digital Object Identifier

10.1177/1074248411427402

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.